L N Maslov, E I Barzakh, A V Krylatov, G A Chernysheva, T Krieg, N V Solenkova, A Yu Lishmanov, S Yu Cybulnikov, Y Zhang
Index: Bull. Exp. Biol. Med. 149(5) , 591-3, (2010)
Full Text: HTML
The cardioprotective properties of a δ₂-opioid receptor agonist deltorphin II were studied in rats with coronary occlusion and reperfusion. Opioid receptor ligands and inhibitors (glybenclamide, chelerythrine, and 5-hydroxydecanoate) were injected intravenously before ischemia and reperfusion. A δ₂-opioid receptor agonist deltorphin II significantly decreased the infarction zone/risk zone index. This effect was abolished by naltrexone, naloxone methiodide, and δ₂-opioid receptor antagonist naltriben, but not by a δ₁-opioid receptor antagonist BNTX. The infarct-limiting effect of deltorphin II was not observed after inhibition of protein kinase C or blockade of mitochondrial K(ATP) channels.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
[D-Ala2] -Deltorphin II
CAS:122752-16-3 |
C38H54N8O10 |
Membrane partitioning of various delta-opioid receptor forms...
2008-06-01 [Biochim. Biophys. Acta 1778(6) , 1483-92, (2008)] |
Delta opioid receptor-mediated analgesia is not altered in p...
2010-12-01 [Eur. J. Neurosci. 32(11) , 1921-9, (2010)] |
Functional identification of a novel transport system for en...
2009-05-01 [Pharm. Res. 26(5) , 1226-35, (2009)] |
Opioid δ(1) and δ(2) receptor agonist attenuate myocardial i...
2011-08-01 [J. Surg. Res. 169(2) , 267-76, (2011)] |
Evidence for two different broad-specificity oligopeptide tr...
2011-06-01 [Am. J. Physiol. Cell Physiol. 300(6) , C1260-9, (2011)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved